Hepatitis B immune globulin (Biotest AG)
N/A
Report date: 2022/01/14 13:23:58
Base Information
Drug NameHepatitis B immune globulin (Biotest AG)
Drug Alias Name +[9]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2009/11/30
Country/Territory +[6]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBiotest Ag
China Registration ClassN/A
Develop Information
Active CompaniesBiotest Pharma Gmbh
Inactive CompaniesHannover Medical SchoolBiotest Ag
Active Indications
Inactive Indications
Other Information
ATC Code
Related LinksKEGG